1. At a Glance – The Smell of Money… or Something Else?
This is a company that literally makes money from dead animal bones… and somehow, the stock market still respects it.
Welcome to Nitta Gelatin — where collagen meets controversy, and profits come wrapped in a faint smell of… regulatory trouble. On one hand, you’ve got a ₹556 Cr revenue business with ₹80+ Cr profit, ROCE of ~25%, and almost no debt. On the other hand? A subsidiary shut down due to pollution violations, a factory accident, minimum wage fines, and a management reshuffle that looks like a corporate musical chairs.
And just when things were getting interesting — boom — one of its key raw material sources (Bamni Proteins) gets shut down for 12–18 months.
So here’s the real question:
Is this a hidden gem quietly compounding… or a ticking time bomb wrapped in gelatin capsules?
Because sometimes, in Indian markets, the best returns come from businesses you’d never want to visit in person.
2. Introduction – From Bones to Balance Sheets
Let’s set the scene.
You’re walking into a factory where animal bones are processed into gelatin, collagen, and chemicals. Not exactly the glamorous side of capitalism. But guess what? This industry quietly feeds into pharma, healthcare, food, and cosmetics — basically everything that makes modern life… tolerable.
Nitta Gelatin India Ltd, incorporated in 1975, is one of those companies that sits in the background — not flashy, not hyped, but quietly minting money.
And here’s the twist — it’s not just any Indian company. It’s a joint venture between the Kerala State Industrial Development Corporation (32%) and a Japanese parent (43%). So you’ve got a mix of government discipline + Japanese precision + Indian jugaad.
Sounds perfect, right?
Except reality isn’t that neat.
Because while the numbers look solid:
- PAT growth has been strong
- ROCE is healthy
- Debt is negligible
There are cracks:
- Sales growth over 5 years: just ~9%
- Heavy reliance on one subsidiary for raw materials
- And that subsidiary just got shut down due to pollution issues
Now pause for a second…
Would you trust a company whose key supplier just got shut down by regulators?
Or would you say: “Boss, something smells off here… and it’s not just gelatin.”
3. Business Model – WTF Do They Even Do?
Let’s simplify this.
They take animal bones → process them → extract proteins → sell them as gelatin and collagen.
That’s it.
Now here’s where it gets interesting.
Core Products:
- Gelatin → used in pharma capsules, food, desserts
- Collagen peptides → beauty, joint health, diabetes products
- DCP (Di-Calcium Phosphate) → poultry feed
- Ossein → intermediate raw material from bones
So basically:
- Pharma companies need them
- Health brands need them
- Poultry farmers need them
Even your gym bro’s protein supplement indirectly needs them.
Revenue Mix:
- ~98% from product sales
- ~46% exports, ~54% domestic
Now here’s the funny part…
This is a commodity business disguised as a specialty play.
Because yes, collagen sounds premium… but at the end of the day, it’s still:
“Bones → Process →
